Emmes Group, a specialized, technology-enabled Contract Research Organization (CRO), has achieved ISO/IEC 27001:2022 certification after a rigorous audit. This data security certificate, widely regarded as the gold standard for Information Security Management Systems (ISMS), guarantees that Emmes Group and its subsidiary companies, Emmes and Veridix, adhere to the highest global standards for safeguarding sensitive information across its workforce, processes, and technology.

The commendation from the International Organization for Standardization (ISO) underscores Emmes Group’s dedication to delivering secure, innovative, and data-driven solutions to its biotech and pharmaceutical partners.

Commenting on the accreditation, Scott Hospes VP of Enterprise Security, Applications and Technology at Emmes Group, said: “We are increasingly now in an age of incredibly data-rich trials, with data gathering and analysis as an integral part of accelerating development timelines and lowering trials costs. Achieving ISO/IEC 27001:2022 certification reflects our dedication to the highest standards of information security and the most up-to-date best practices. This independent verification fosters greater trust in our data handling processes and solidifies our position as a leader in the industry’s transformation toward AI-driven and digital-native clinical research.”